-
Published:
Monday, February 06, 2012
Gleevec and Herceptin (and their clinical and commercial success), were pioneering drugs in terms of embarking us into an age o...
-
Published:
Monday, February 06, 2012
Pharmaceutical company sales and marketing data has never been close to the league of quality of the Business-to-Consumer (B2C)...
-
Published:
Monday, January 09, 2012
A lot of attention is currently on the larger emerging markets that have significantly more growth than the mature markets. The...
-
Published:
Monday, January 09, 2012
January 2012: the beginning of a new year, with new hopes and dreams. So where have we got to in Pharma, and what is on the age...
-
Published:
Thursday, December 15, 2011
Much of marketing is based on setting expectations (forecasts) and meeting these (sales achieved). Taking that a step further, ...
-
Published:
Monday, December 05, 2011
Most therapeutic markets in the Pharmaceutical Industry are already becoming crowded (and some even saturated), and yet more co...
-
Published:
Monday, December 05, 2011
In Part 1 of this article we examined some of the barriers to doing business in China that our Clients have found. These includ...
-
Published:
Thursday, November 24, 2011
On the face of it, marketing Oncology drugs is a highly lucrative business for the Pharmaceutical industry.
Therefore, the op...
-
Published:
Thursday, November 24, 2011
There are numerous barriers to growing your brand(s) in China, and not all are easy to overcome. Nonetheless, there is also vas...
-
Published:
Friday, October 14, 2011
‘Virtual Pharma’ is not a new idea but is a valid one that has yet to be properly exploited to full advantage by many Pharmaceu...